Scholarly Index
Thomas Prébet
Bristol-Myers Squibb (United States); 8,454 total citations; 300 total publications; best world rank #355
Bristol-Myers Squibb (United States)
8,454Total citations
300Total publications
47H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Acute Myeloid Leukemia Research | Lifetime | 562 | US 262 | 98.50 |
| Histone Deacetylase Inhibitors Research | Lifetime | 355 | US 186 | 96.71 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 603 | US 251 | 95.89 |
| Protein Degradation and Inhibitors | Lifetime | 994 | US 478 | 93.88 |
| Acute Myeloid Leukemia Research | 2021-2025 | 516 | US 245 | 95.42 |
| Neutropenia and Cancer Infections | 2021-2025 | 424 | US 145 | 79.23 |